FDA Drug Recalls

Recalls / Class II

Class IID-0153-2021

Product

Kaiser Permanente Clotrimazole Cream USP, 1% Antifungal Cream, NET WT 1 oz (28.4 g), Manufactured by Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T1C1 Distributed by Kaiser Foundation Hospitals Livemore, CA 94551-9756. Made in Canada. NDC 0179-8014-30

Affected lot / code info
Lot#: A873630634, Exp Dec 2020; B870030634, Exp, Jan 2021

Why it was recalled

Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.

Recalling firm

Firm
Taro Pharmaceuticals U.S.A., Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
3 Skyline Dr, N/A, Hawthorne, New York 10532-2174

Distribution

Quantity
30,816 1 oz tubes
Distribution pattern
Distributed Nationwide in the USA and Canada

Timeline

Recall initiated
2020-11-17
FDA classified
2020-12-16
Posted by FDA
2020-12-23
Terminated
2024-02-21
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0153-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.